Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Cholecalciferol × 1 year × Clear all

Sponsor

Conditions

Vitamin D Deficiency 3 Prostatic Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Psoriasis 1 Osteoporosis Secondary 1 Osteoarthritis 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Adenocarcinoma 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Bone Metabolism Biomarkers 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡